These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33370719)

  • 21. Beta conformation of polyglutamine track revealed by a crystal structure of Huntingtin N-terminal region with insertion of three histidine residues.
    Kim M
    Prion; 2013; 7(3):221-8. PubMed ID: 23370273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM; Bottomley SP
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structural impact of a polyglutamine tract is location-dependent.
    Robertson AL; Horne J; Ellisdon AM; Thomas B; Scanlon MJ; Bottomley SP
    Biophys J; 2008 Dec; 95(12):5922-30. PubMed ID: 18849414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins.
    Krobitsch S; Lindquist S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1589-94. PubMed ID: 10677504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
    Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
    J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
    Garden GA; La Spada AR
    Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.
    Adegbuyiro A; Sedighi F; Pilkington AW; Groover S; Legleiter J
    Biochemistry; 2017 Mar; 56(9):1199-1217. PubMed ID: 28170216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.
    Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation.
    Bhutani N; Venkatraman P; Goldberg AL
    EMBO J; 2007 Mar; 26(5):1385-96. PubMed ID: 17318184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling the polyglutamine aggregation pathway in Huntington's disease: from basic studies to clinical applications.
    Sugaya K
    Subcell Biochem; 2012; 65():353-88. PubMed ID: 23225011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract.
    Bravo-Arredondo JM; Kegulian NC; Schmidt T; Pandey NK; Situ AJ; Ulmer TS; Langen R
    J Biol Chem; 2018 Dec; 293(51):19613-19623. PubMed ID: 30315108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformation Polymorphism of Polyglutamine Proteins.
    Feng X; Luo S; Lu B
    Trends Biochem Sci; 2018 Jun; 43(6):424-435. PubMed ID: 29636213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
    Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
    Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance.
    Hoop CL; Lin HK; Kar K; Hou Z; Poirier MA; Wetzel R; van der Wel PC
    Biochemistry; 2014 Oct; 53(42):6653-66. PubMed ID: 25280367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Protein Structure Context of PolyQ Regions.
    Totzeck F; Andrade-Navarro MA; Mier P
    PLoS One; 2017; 12(1):e0170801. PubMed ID: 28125688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing the possible inhibition of proteasome by direct interaction with ubiquitylated and aggregated huntingtin.
    Valera AG; Díaz-Hernández M; Hernández F; Lucas JJ
    Brain Res Bull; 2007 Apr; 72(2-3):121-3. PubMed ID: 17352935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and dynamic studies reveal that the Ala-rich region of ataxin-7 initiates α-helix formation of the polyQ tract but suppresses its aggregation.
    Hong JY; Wang DD; Xue W; Yue HW; Yang H; Jiang LL; Wang WN; Hu HY
    Sci Rep; 2019 May; 9(1):7481. PubMed ID: 31097749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.
    Wetzel R
    J Mol Biol; 2012 Aug; 421(4-5):466-90. PubMed ID: 22306404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins.
    Venkatraman P; Wetzel R; Tanaka M; Nukina N; Goldberg AL
    Mol Cell; 2004 Apr; 14(1):95-104. PubMed ID: 15068806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards the treatment of polyglutamine diseases: the modulatory role of protein context.
    Robertson AL; Bottomley SP
    Curr Med Chem; 2010; 17(27):3058-68. PubMed ID: 20629626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.